PDF(Pubmed)
Abstract：
The COVID-19 pandemic had a major impact on health systems worldwide, and Romania was no exception. The impact on healthcare expenses for pregnant women was considerable, especially in COVID-19-only tertiary centers. This study aimed to analyze the impact of the COVID-19 pandemic on healthcare costs in a designated COVID-19 maternity ward. We conducted an observational study comparing pregnant women with SARS-CoV-2 (study group) to those without the infection (control group). Patients were recruited at Bucur Maternity Hospital from March 2020 to March 2022. We evaluated expenses for the entire period of hospitalization, treatment, medical supplies, and medical investigations. The study included 600 pregnant women, divided equally into two groups of 300 each. Significant cost differences were observed between the COVID-19 and non-COVID-19 groups: medication costs (664.56 EUR vs. 39.49 EUR), administrative costs (191.79 EUR vs. 30.28 EUR), and medical investigation costs (191.15 EUR vs. 29.42 EUR). The costs for a severe case of COVID-19 were about two times higher than a mild case and 70 times higher than a non-COVID-19 case (P <0.001). We identified a significant cost increase due to SARS-CoV-2 infection in our unit. The expenses were augmented by the time of hospitalization, medication, and medical investigations. COVID-19 had a significant impact on healthcare costs, mostly among pregnant women with severe disease. The strategy of operating exclusively as a COVID-19 unit proved to be inefficient and highly costly to our hospital.
摘要：
COVID-19大流行对全球卫生系统产生了重大影响，罗马尼亚也不例外。对孕妇医疗费用的影响相当大，特别是在仅限COVID-19的三级中心。本研究旨在分析COVID-19大流行对指定COVID-19产科病房医疗费用的影响。我们进行了一项观察性研究，将患有SARS-CoV-2的孕妇（研究组）与没有感染的孕妇（对照组）进行了比较。患者于2020年3月至2022年3月在Bucur妇产医院招募。我们评估了整个住院期间的费用，治疗,医疗用品,和医学调查。这项研究包括600名孕妇，平均分为两组，每组300人。COVID-19和非COVID-19组之间观察到显著的费用差异：药物费用（664.56欧元与39.49欧元），管理费用（191.79欧元与30.28欧元），和医疗调查费用（191.15欧元对29.42欧元）。严重的COVID-19病例的费用是轻度病例的两倍，是非COVID-19病例的70倍(P<0.001)。我们发现，由于SARS-CoV-2感染，我们单位的费用显着增加。住院时间增加了费用，药物,和医学调查。COVID-19对医疗成本产生了重大影响，主要是患有严重疾病的孕妇。事实证明，完全作为COVID-19单位运作的策略对我们医院来说是低效和高成本的。
